17-Alpha-Hydroxyprogesterone vs. Placebo for Preventing of Recurrent Preterm Birth: A Systematic Review and Meta-Analysis of Randomized Trials
Background: Preterm birth (PTB) is a leading cause of neonatal morbidity and mortality.Objective: To estimate the effect of 17-alpha-hydroxyprogesterone caproate (17-OHPC) compared to placebo in singleton gestations for reducing the risk of recurrent PTB and neonatal morbidity and mortality.Work Des...
Guardado en:
Autores principales: | Abdulaali R. Almutairi, Hadir I. Aljohani, Nouf S. Al-fadel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/97757e12be8148e986df4832561914db |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
17-alpha hydroxyprogesterone caproate for the prevention of recurrent preterm birth among singleton pregnant women with a prior history of preterm birth: a systematic review and meta-analysis of six randomized controlled trials
por: Saeed Baradwan, et al.
Publicado: (2021) -
Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birth
por: Travanty MN, et al.
Publicado: (2018) -
Feasibility and design of a trial regarding the optimal mode of delivery for preterm birth: the CASSAVA multiple methods study
por: Jane E Norman, et al.
Publicado: (2021) -
Right Ventricular Structure and Function in Young Adults Born Preterm at Very Low Birth Weight
por: Charlotte Greer, et al.
Publicado: (2021) -
ROLE OF CYTOXIC T-LYMPHOCYTES IN THE PATHOGENESIS OF PRETERM BIRTH
por: N. R. Radzhabova, et al.
Publicado: (2021)